Unknown

Dataset Information

0

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.


ABSTRACT: During the course of our research efforts to develop a potent and selective γ-secretase inhibitor for the treatment of Alzheimer's disease, we investigated a series of carboxamide-substituted sulfonamides. Optimization based on potency, Notch/amyloid-β precursor protein selectivity, and brain efficacy after oral dosing led to the discovery of 4 (BMS-708163). Compound 4 is a potent inhibitor of γ-secretase (Aβ40 IC50 = 0.30 nM), demonstrating a 193-fold selectivity against Notch. Oral administration of 4 significantly reduced Aβ40 levels for sustained periods in brain, plasma, and cerebrospinal fluid in rats and dogs.

SUBMITTER: Gillman KW 

PROVIDER: S-EPMC4007960 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4018072 | biostudies-literature
| S-EPMC7025382 | biostudies-literature
| S-EPMC4018057 | biostudies-literature
| S-EPMC3109749 | biostudies-literature
| S-EPMC7294707 | biostudies-literature
| S-EPMC4018154 | biostudies-literature
| S-EPMC4007909 | biostudies-other
| S-EPMC4007840 | biostudies-other
| S-EPMC4025788 | biostudies-other
| S-EPMC10473160 | biostudies-literature